Tryn Stimart insider trades
Open-market stock purchases and sales by Tryn Stimart, Chief Legal Officer at AbCellera Biologics Inc, from SEC Form 4 filings since Oct 29, 2020.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -42%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 1, 2026 | ABCL AbCellera Biologics Inc | Bought (not open market) | — |
Companies traded
- ABCL AbCellera Biologics Inc: 1 buy, 1 sale, last Jan 1, 2026